Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Growth hormone sermorelin

GHRH is not currently available commercially in research use it may be administered intravenously, subcutaneously, or intranasally, and the relative potencies (defined as incremental growth hormone release) by these three routes are 300, 10, and 1, respectively. Intravenous GHRH (1 g/kg) has a distribution half-life of 4 minutes and an elimination half-life of 53 minutes. Subcutaneous GHRH has a similar elimination half-life but a distribution half-life of about 10 minutes. Peak serum levels of GHRH (1 g/kg) are 37 times higher after intravenous administration compared with subcutaneous injection. Sermorelin, 2 g/kg subcutaneously, reaches peak serum concentrations in 5-20 minutes its bioavailability is 6%. The half-life of sermorelin is about 12 minutes after either subcutaneous or intravenous injection. [Pg.852]

Growth hormone releasing hormone (GHRH), sermorelin... [Pg.258]

Geref Sermorelin Growth hormone deficiency Serono Expired (2004)... [Pg.37]

Sermorelin is an analogue of the hypothalamic growth hormone releasing hormone (somatorelin) it is used in a diagnostic test for growth hormone secretion from the pituitary. [Pg.710]

USA sermorelin acetate peptide Geref Recombinant 1-29 residues of human growth hormone-releasing hormone Hormone... [Pg.480]

Sermorelin, a growth-hormone-releasing hormone, is used as a diagnostic aid to determine the pituitary gland s ability to secrete growth hormone. [Pg.640]

See other pages where Growth hormone sermorelin is mentioned: [Pg.388]    [Pg.343]    [Pg.413]    [Pg.852]    [Pg.852]    [Pg.852]    [Pg.260]    [Pg.137]    [Pg.144]    [Pg.149]    [Pg.255]    [Pg.1416]    [Pg.1417]   
See also in sourсe #XX -- [ Pg.1416 ]



SEARCH



Growth hormones

Sermorelin

© 2024 chempedia.info